Pennsylvania Senate Majority Policy Committee hearings on election fraud at the request of Republican senator Doug Mastriano

Wednesday, November 25, 2020: At the request of Senator Doug Mastriano (R-Adams/Cumberland/Franklin/York), the Senate Majority Policy Committee is held a public hearing Wednesday to discuss 2020 election issues and irregularities.

WHO: Senate Majority Policy Committee Chair David Argall (R-Berks/Schuylkill); Senate Majority Leader-Elect Kim Ward (R-39); State Rep. Dan Moul (R-91); State Rep. Rob Kauffman (R-89); and State Rep Paul Schemel (R-90); among other lawmakers will join Senator Mastriano in this historic hearing.

“Elections are a fundamental principle of our democracy – unfortunately, Pennsylvanians have lost faith in the electoral system,” said Mastriano, who recently called for the resignation of State Department Secretary Kathy Boockvar for negligence and incompetence. “It is unacceptable.”

“Over the past few weeks, I have heard from thousands of Pennsylvanians regarding issues experienced at the polls, irregularities with the mail-in voting system and concerns whether their vote was counted,” said Mastriano. “We need to correct these issues to restore faith in our republic.” “We want assurance that the issues encountered during this past election don’t happen again,” said Chairman Argall. “Senator Mastriano requested this meeting because Pennsylvanians deserve a fair election.” Nick Note: Look at the tape… Very very credible witnesses testify to POTENTIAL massive organized voter fraud. The french concluded that mail in elections were impossible to be fair. And opened up elections to massive fraud. through huge data breaches and hacking of computerized counting machines. It is obvious that something is very fishy in Denmark. Unfortunately these allegations are coming too late in the process. But you never know. Part of the problem is Trumps legale fight is about as organized as a rain deer round up!

Biden can enter WH only if proves all his votes were legal – Trump

https://youtu.be/ksvttXWJ8p4

Less than 24 hours after Donald Trump said he was ready to step aside for president-elect Joe Biden, he has reversed his position, claiming that Biden must first “prove” he actually won the 80 million votes that states across the US have counted in his favour. On Friday, a federal appeals court panel in Philadelphia shot down Trump’s legal team’s attempt to challenge election results in Pennsylvania, a state Biden won. Yet in a tweet completely detached from reality, Trump insisted that it’s now Biden who has a “big unsolvable problem.”

The president-elect can “only enter the White House as president if he can prove that his ridiculous ‘80,000,000 votes’ were not fraudulently or illegally obtained,” Trump tweeted Friday.

He did not indicate how Biden was expected to prove the legitimacy of votes that have already gone through a certification process. Trump also falsely said Biden only did well in the large cities of Detroit, Philadelphia, Atlanta and Milwaukee, which he claimed have “long [been] known as being politically corrupt.” Trump won the states of Michigan, Pennsylvania, Georgia and Wisconsin in 2016, but not this year. Twitter marked both of Trump’s tweets as “disputed.”

“Charges of unfairness are serious. But calling an election unfair does not make it so. Charges require specific allegations and then proof. We have neither here,” Trump appointee Judge Stephanos Bibas wrote in an opinion filed Friday for the three-judge panel of the 3rd U.S. Circuit Court of Appeals. The judges on the panel were all appointed by GOP presidents. “Voters, not lawyers, choose the president. Ballots, not briefs, decide elections,” the court said. “The campaign cannot win this lawsuit.” When reporters had asked Trump on Thursday if he would leave the White House when his term is up, the president had responded: “Certainly I will… Certainly I will, and you know that.” But he also said it was “going to be a very hard thing to concede” and again falsely insisted there “was massive fraud.”  Members of the US’ electoral college will meet on December 14 to cast their votes in their respective states, a move that constitutionally determines the next president. Trump refused to say on Thursday if he planned to attend Biden’s inauguration. The president golfed on Friday at his club in Virginia before traveling on Marine One to Camp David.  Nick Note: Trump chances  of over turning the election in the courts are now 1 in a 100. But that is not where we should focus our attention. Is what other non judicial mover he could make.  And imagine the damage a aggrieved President could do if he believes the election was stolen from him. Is Trump vindictive? Does a cat eat mice?  Bomb Iran is on the Table.. After all he authorized the assignation of Iran’s top Nuclear scientist. He has taken over the pentagon and chief of staff with his loyalists. These are strategic moves…… He is certainly laying the ground work for something spectacular. The only question is will he pull the pin on the grenade as he is forced out of office..

The Stock Market and Derivatives Are Sending Different Signals

The Dow soared back to a record this week, but Wall Street’s fear gauge also remains elevated

Rising stock indexes suggest investors are breathing a sigh of relief right now. Wall Street’s fear gauge says otherwise, though. Stocks have soared back to records, fueled by optimism about a coming vaccine for the novel coronavirus as well as relief that the election—widely anticipated for months—has passed. The Dow Jones Industrial Average has rallied 12.7% in November, on track for its strongest month since 1987. The S&P 500 has advanced 11% this month and hit a high on Tuesday Although market volatility has edged lower in recent days, the Cboe Volatility Index has hovered above 20 since Feb. 24, marking 194 consecutive trading sessions that it has not closed below that threshold. That is the longest such streak since one ending in 2009 during the financial crisis, according to Dow Jones Market Data. The gauge is based on options prices tied to the S&P 500 and tends to fall as stocks are rising. The VIX at an elevated level signals investors remain cautious despite a stock market that is flying high, with concerns lingering that the volatility that gripped markets earlier in the year could return. It also reflects elevated prices for options bets tied to the S&P 500, which investors often tap to hedge portfolios or make directional bets on stocks. The stretch is remarkable because it includes a period in which U.S. stocks tumbled into a bear market—defined as a drop of at least 20%—before rebounding back toward new highs. Despite the recent ascent for stocks, the elevated VIX signals some anxiety about the market’s path. Since Feb. 24, the S&P 500 has gained about 12.5%.

In six out of eight of the past periods where the VIX hovered above 20 for at least 100 sessions, the S&P 500 had fallen, not risen, according to Dow Jones Market Data.

“There’s still a lot of scars from what happened earlier in the year,” said Chris Murphy, co-head of derivatives strategy at Susquehanna. Some analysts said the elevated VIX has been driven by doubts about the recent stock rally, driving demand for insurance-like contracts through the end of the year to protect recent gains.

“There’s so much uncertainty out there,” said Stuart Kaiser, head of equity derivatives research at UBS Group AG . “Nobody wants to be on the wrong side of this.”

Despite positive news about the vaccine recently, it isn’t clear when it will be distributed and how quickly the economy will bounce back. And of course, it has been a rocky year. There have been more single-day stock moves of at least 3% for the Dow Jones Industrial Average, S&P 500 and Nasdaq Composite—up or down—than in any year since 2008.

There are some signs that traders are positioning for the gauge to snap its streak above 20 and plummet. Leveraged funds like hedge funds recently ramped up wagers that would pay out if the VIX fell. Commodity Futures Trading Commission data show such wagers recently hit their highest level since at least early August. Bearish bets like these on the volatility gauge are akin to bullish ones on stocks.

Meanwhile, there has been a flurry of bullish call options activity tied to the iShares Russell 2000 exchange-traded fund, which tracks shares of small companies. The Russell 2000 is up 20% this month, on track for its best month since its 1984 inception. Investors confident that the economy will continue to improve because of the vaccine have piled into the sector. Nick Note:  My dick is hard… Please GOD get it HIGHER… I want to buy a fleet of the new 1000 HP EV Hummers. And then rip that electrics shit out for my solar panels ant put in  proper big block! like the ZZ572/620….727 HONEST HORSEPOWER. And the really neat part is i am doing my part to kill the ozone layer and get rid of those left over from the tropic age all those nasty ice caps…

Every hour, 65 Americans are dying; AstraZeneca plans additional trial after error; hospitalizations hit record, again

https://youtu.be/Aw6egSqLp3I

The deadly reality of America’s bitter battle against coronavirus was obvious to families that gathered across the country for Thanksgiving dinner: There were empty seats around the table. In Deer Park, New York, Vivian Zayas replaced a seat from the table at her home with her late mother’s walker. She scrolled through photos of last Thanksgiving, when her mother, Ana Martinez, who died in April of COVID-19, stood at the stove making a pot of rice and beans. For Jessica Franz, a nurse who works the graveyard shift at Olathe Medical Center in a Kansas suburb, a typical year would have her mother-in-law laying out a feast for her children. That didn’t happen this year: Elaine Franz died of the coronavirus on Nov. 10, a day before her 78th birthday. The number of COVID-19 hospitalizations continues to rise, hitting a record for the 17th straight day Thursday with more than 90,400 admissions, according to the COVID Tracking Project. Tuesday and Wednesday saw record deaths of over 2,100 each day, according to John Hopkins University data.  Every minute, 114 Americans are testing positive for COVID-19, according to Johns Hopkins University data. Every hour, 65 Americans are dying.  The turnaround time for test results is lagging, too. Amid a record demand ahead of the Thanksgiving weekend, Quest Diagnostics said this week that it’s taking up to three days to complete a test after receiving a sample. LabCorp, another large private lab company, reported tests now taking up to two days. The U.S. has reported more than 12.8 million cases and over 263,400 deaths, according to Johns Hopkins University data. This week week, five states set death records and 23 states had higher case counts than last week. The global totals: more than 61 million cases and 1.4 million deaths.

Trump: It’ll be very hard to concede due to massive fraud

WASHINGTON — President Donald Trump said Thursday that he will leave the White House if the Electoral College formalizes President-Elect Joe Biden’s victory — even as he insisted such a decision would be a “mistake” — as he spent his Thanksgiving renewing baseless claims that “massive fraud” and crooked officials in battleground states caused his election defeat.

“Certainly I will. But you know that,” Trump said Thursday when asked whether he would vacate the building, allowing a peaceful transition of power in January. But Trump — taking questions for the first time since Election Day — insisted that “a lot of things” would happen between now and then that might alter the results.“This has a long way to go,” Trump said, even though he lost.

The fact that a sitting American president even had to address whether or not he would leave office after losing reelection underscores the extent to which Trump has smashed one convention after another over the last three weeks. While there is no evidence of the kind of widespread fraud Trump has been alleging, he and his legal team have nonetheless been working to cast doubt on the integrity of the election and trying to overturn voters’ will in an unprecedented breach of democratic norms. Trump spoke to reporters in the White House’s ornate Diplomatic Reception Room after holding a teleconference with U.S. military leaders stationed across the globe. He thanked them for their service and jokingly warned them not to eat too much turkey, then turned to the election after ending the call. He repeated grievances and angrily denounced officials in Georgia and Pennsylvania, two key swing states that helped give Biden the win.

Trump claimed, despite the results, that this may not be his last Thanksgiving at the White House. And he insisted there had been “massive fraud,”

even though state officials and international observers have said no evidence of that exists and Trump’s campaign has repeatedly failed in court. Trump’s administration has already given the green light for a formal transition to get underway. But Trump took issue with Biden moving forward. “I think it’s not right that he’s trying to pick a Cabinet,” Trump said, even though officials from both teams are already working together to get Biden’s team up to speed. And as he refused to concede, Trump announced that he will be travelling to Georgia to rally supporters ahead of two Senate runoff elections that will determine which party controls the Senate. Trump said the rally for Republican Sens. David Perdue and Kelly Loeffler would likely be held Saturday. The White House later clarified he had meant Dec. 5. One of the reasons Republicans have stood by Trump and his baseless claims of fraud has been to keep his loyal base energized ahead of those runoffs on Jan. 5. But Trump, in his remarks, openly questioned whether that election would be fair in a move that could dampen Republican turnout.

“I think you’re dealing with a very fraudulent system. I’m very worried about that,” he said. “People are very disappointed that we were robbed.”

As for the Electoral College, Trump made clear that he will likely never formally concede, even if he said he would leave the White House.

“It’s gonna be a very hard thing to concede. Because we know there was massive fraud,” he said, noting that, “time isn’t on our side.” “If they do,” vote against him, Trump added, “they’ve made a mistake.”

Asked whether he would attend Biden’s inauguration, Trump said he knew the answer but didn’t want to share it yet. But there were some signs that Trump was coming to terms with his loss. At one point he urged reporters not to allow Biden the credit for pending coronavirus vaccines. “Don’t let him take credit for the vaccines because the vaccines were me and I pushed people harder than they’ve ever been pushed before,” he said. As for whether or not he plans to formally declare his candidacy to run again in 2024 — as he has discussed with aides — Trump said he didn’t “want to talk about 2024 yet.” All states must certify their results before the Electoral College meets on Dec. 14, and any challenge to the results must be resolved by Dec. 8. States have already begun that process, including Michigan, where Trump and his allies tried and failed to delay the process, and Georgia and Pennsylvania. Vote certification at the local and state level is typically a ministerial task that gets little notice, but that changed this year with Trump’s refusal to concede and his unprecedented attempts to overturn the results of the election through a fusillade of legal challenges and attempts to manipulate the certification process in battleground states he lost. Biden won by wide margins in both the Electoral College and popular vote, where he received nearly 80 million votes, a record. Nick Note: When the most powerful man in the world tells you this election has got a long way to go it would be wise not to blow it off. His chances of pulling a rabbit out of his hat is now down to less then 10%. BUT BUT I am sure he is contemplating great evil… So you have to say the potential is their……. He is certainley laying the ground work.

AstraZeneca manufacturing error clouds vaccine study results

LONDON (AP) — AstraZeneca and Oxford University on Wednesday acknowledged a manufacturing error that is raising questions about preliminary results of their experimental COVID-19 vaccine. A statement describing the error came days after the company and the university described the shots as “highly effective” and made no mention of why some study participants didn’t receive as much vaccine in the first of two shots as expected. In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses. In the low-dose group, AstraZeneca said, the vaccine appeared to be 90% effective. In the group that got two full doses, the vaccine appeared to be 62% effective. Combined, the drugmakers said the vaccine appeared to be 70% effective. But the way in which the results were arrived at and reported by the companies has led to pointed questions from experts. The partial results announced Monday are from large ongoing studies in the U.K. and Brazil designed to determine the optimal dose of vaccine, as well as examine safety and effectiveness. Multiple combinations and doses were tried in the volunteers. They were compared to others who were given a meningitis vaccine or a saline shot.

DID RESEARCHERS MEAN TO GIVE A HALF DOSE?

Before they begin their research, scientists spell out all the steps they are taking, and how they will analyze the results. Any deviation from that protocol can put the results in question.

In a statement Wednesday, Oxford University said some of the vials used in the trial didn’t have the right concentration of vaccine so some volunteers got a half dose.

The university said that it discussed the problem with regulators, and agreed to complete the late stage trial with two groups. The manufacturing problem has been corrected, according to the statement. Experts say the relatively small number of people in the low dose group makes it difficult to know if the effectiveness seen in the group is real or a statistical quirk. Some 2,741 people received a half dose of the vaccine followed by a full dose, AstraZeneca said. A total of 8,895 people received two full doses. Another factor: none of the people in the low-dose group were over 55 years old. Younger people tend to mount a stronger immune response than older people, so it could be that the youth of the participants in the low-dose group is why it looked more effective, not the size of the dose. Another point of confusion comes from a decision to pool results from two groups of participants who received different dosing levels to reach an average 70% effectiveness, said David Salisbury, and associate fellow of the global health program at the Chatham House think tank. “You’ve taken two studies for which different doses were used and come up with a composite that doesn’t represent either of the doses,″ he said of the figure. “I think many people are having trouble with that.″

WHY WOULD A SMALLER FIRST DOSE BE MORE EFFECTIVE?

Oxford researchers say they aren’t certain and they are working to uncover the reason. Sarah Gilbert, one of the Oxford scientists leading the research, said the answer is probably related to providing exactly the right amount of vaccine to trigger the best immune response. “It’s the Goldilocks amount that you want, I think, not too little and not too much. Too much could give you a poor quality response as well,” she said. “So you want just the right amount and it’s a bit hit and miss when you’re trying to go quickly to get that perfect first time.” Details of the trial results will be published in medical journals and provided to U.K. regulators so they can decide whether to authorize distribution of the vaccine. Those reports will include a detailed breakdown that includes demographic and other information about who got sick in each group, and give a more complete picture of how effective the vaccine is. Moncef Slaoui, who leads the U.S. coronavirus vaccine program Operation Warp Speed, said Tuesday in a call with reporters that U.S. officials are trying to determine what immune response the vaccine produced, and may decide to modify the As results. AstratraZeneca study in the U.S. to include a half dose. “But we want it to be based on data and science,” he said. Nick Note: Who knows what sins lie in the data. Do you really want a warp speed vaccine? I prefer till i see the test monkey results. That is our friends and neighbors… Let me know how it works out

California’s Massive Number Of New Coronavirus Cases Jumps 17% In 24 Hours, Sets Another Record

As millions of Californians are traveling and gathering for Thanksgiving, the state is experiencing an unprecedented surge in infections and hospitalizations. The state has seen its three highest tallies of new cases ever in the past five days. On Tuesday, the number of new infections was 15,329. That’s down slightly from what was the all time high of 15,442 on Saturday, but Wednesday’s number dwarfed them both at 18,350. That’s a 17% jump in cases in 24 hours and a rise so steep that the state’s line graph for daily cases is nearly vertical.

“Statewide, I don’t think we’ve ever seen hospital admissions increase like we did just over the past 24 hours,” said California Director of Health and Human Services Dr. Mark Ghaly on Tuesday. “I hope but don’t expect that it’s the highest we’ll ever have.”

Ghaly was right. Just 24 hours later, the number of hospitalizations jumped another 5%, with 408 new patients recorded. As Deadline reported Tuesday, the daily number of hospitalizations due to the virus in California had increased 81% in the 14 days prior, to 6,641. Wednesday’s number brought the number of Covid-19 patients hospitalized in the state to 7,049, which is approaching the all-time high of 8,820 hospitalizations seen on July 21.

Ghaly reminded that today’s hospitalizations are the result of the number of infections seen two weeks prior. So Tuesday’s patients are based on a case number of 7,000 that we saw on November 10. Tuesday’s daily new case count was 15,329, more than double that from two weeks ago. “We’re concerned,” said Ghaly about what lies ahead. According to Ghaly and others, Covid-19-related hospitalizations down the road have worked out to be 12% of the daily infections number. That means the number of new hospitalizations resulting from Tuesday’s new case count will be 1,839. The number of new hospitalizations resulting from Saturday’s new cases will be 1,853 in two weeks. According to Gov. Gavin Newsom, 44,369 of the state’s 73,867 hospital beds were occupied on Monday. That seems like a good cushion, but even just a week of new admissions in the range of 1,800 is another 12,600 beds occupied. Two weeks at that rate is another 25,200 beds taken up. Adding that to the Monday’s total would have about 70,000 of the state’s 73,867 beds full. And those are just Covid-19 cases. That number does not account for the state’s usual daily demand due to other maladies. Test positivity rates present more evidence of the state’s crisis. In the past week, California is delivering far more tests per day than it ever has, yet the positivity rate continues to grow. That means the actual number of infections in the population is growing. The 14-day test positivity rate is now 5.9%. That’s up 2% over the past two weeks. California has 40 million residents. A 2% jump in infections in a population that size could represent up to 800,000 additional cases. Despite pleas from state and local officials urging residents not to travel for Thanksgiving due to the coronavirus, millions of Southern Californians are still expected to do just that, with this afternoon anticipated to be the busiest time on Southland freeways. The Automobile Club of Southern California estimated that 3.86 million Southern California residents will be traveling for the holiday weekend, a 13% drop from last year. Health authorities have been recommending against travel this Thanksgiving due to surging COVID-19 cases. The state has issued a travel advisory, urging people who do travel to quarantine for 14 days upon their return. Travelers coming through Los Angeles International and Van Nuys airports and Union Station beginning Wednesday will be required to sign a form acknowledging California’s recommended 14-day self quarantine in response to rising coronavirus rates. During a Monday briefing, Mayor Eric Garcetti urged people to not travel over the Thanksgiving holiday, not even to go across town because of how widespread Covid-19 cases have been recently.

Nick Note: how is this going to work. You cannot get them to isolate or even wear a mask. And now you are going to get them to voluntarily isolate. This is going to end up in the slaughter of baby Boomers

The AstraZeneca Covid Vaccine Data Isn’t Up to Snuff

There were other dosing issues, too, that haven’t been explained even though dosing is the centerpiece of the press release. There are many different regimens in these trials—the UK study has more than two dozen arms, meaning the volunteers were divided into that many groups according to age and how much of the vaccine would be administered and when. The doses are measured by the number of altered viral particles they contain, and the developers decided that the standard dose would be 5 x 1010 viral particles. But for many of those arms in the UK trial—as well as everyone who got the vaccine in the Brazilian trial—publicly available trial information shows that the standard dose could be between 3.5 and 6.5 × 1010 viral particles. The lower end of that range isn’t far off from a half-dose. How did Oxford-AstraZeneca end up with this patched-together analysis instead of data from a single, large trial? After all, this vaccine went into Phase 3 testing before either BNT-PFizer’s or Moderna’s did. But in the UK, where that testing started, the Covid-19 outbreak happened to be receding. That meant results would be coming in very slowly. A month later, a second Phase 3 trial for the vaccine started in Brazil. That one was for healthcare workers, for whom the risk of being exposed to Covid was far higher than it was for the people in the UK trial. But the two trials had other substantive differences. In the UK, for example, the volunteers who did not get the experimental Covid vaccine were injected with meningococcal vaccine; in Brazil, those in the comparison group were given a saline injection as a placebo. Meanwhile, BNT-Pfizer and Moderna began Phase 3 trials for their coronavirus vaccines on the same day in July: Both planned to include 30,000 volunteers at the time, and both trial plans were approved by the FDA. Oxford-AstraZeneca then announced they, too, would run a 30,000-person trial in the US. But that research on the Oxford-AstraZeneca vaccine quickly fell behind the others’. The US trial was approved by the FDA, but it didn’t start recruiting people until the end of August; and just a week later, it was put on hold so the FDA could investigate a serious adverse event in the UK trial. It wasn’t clear what caused the volunteer to get sick, but the FDA did not give the all-clear for Oxford-AstraZeneca’s US trial to resume until Oct. 23. By then the protocol for the trial had been publicly released. It says the plan is to inject the vaccine in two standard doses, a month apart; and two people will be vaccinated for every one who gets a placebo saline injection. So here we are at the end of November. BNT-Pfizer and Moderna have offered up a masterclass in how to do major vaccine trials quickly in a pandemic, while Oxford-AstraZeneca has, for the moment, only an assortment of smaller ones ready to look at. But wait, more red flags! Last week, Oxford-AstraZeneca published some results from earlier in the development of the UK trial. That paper included a trial protocol for the UK study, attached as an appendix.

Deep in that document, and apparently overlooked by reporters and commentators, was an eyebrow-raising suggestion: Under a section marked “Interim and primary analyses of the primary outcome,” the trialists outline a plan to combine and analyze data from four clinical trials (only half of which are Phase 3), carried out in different ways on three different continents.

The plan, they wrote, was to pull out results only for the people across these four trials who had gotten “two standard-dose vaccines,” and then pool those together for what’s called a meta-analysis. Nick Note: I am reading ALL the studies as they are released. To say the least they are very rushed and the lack to me credibility. Why am i doing this. Well the great white hope for the world economy is stopping this killer virus. And it is killing more and more people each and every day. So what ever they are doing its not working. The stock market is in one of its biggest mindless rally ever. (Thats how i make my money! ) A rally based on self serving headlines and political spinwill always end in disaster. Based on headlines THEY DROVE THE MARKETS TO RECORD HIGHS IN THE MIDDLE OF A DEPRESSION NO ONE ADMITS WE ARE IN. Its like trading support and resistance lines or Gann Fans it sounds good but does not work . I wish it was that easy. My analysis is the virus is far from beaten and these 6 month wonder drugs are not all they are cracked up to be.. Their is no vaccine and if one of these happens to work it will take 2 years before this shit is over. See the Lancet Study below….. It makes great reading:

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine

Nick Bit: One of member who was involved in clinical studies told me his boss said the following:

“If you torture the data enough it will confess to anything”

This is the most tortured data i have ever seen

Unemployment Claims Are Rising Again Amid Covid-19 Surge

Weekly jobless claims ticked up for the second week in a row to 778,000 (on a seasonally adjusted basis), significantly more than the 733,000 claims experts were expecting—the data is a discouraging sign that the record-breaking surge in Covid-19 cases is beginning to impact the labor market.

Lawmakers in Washington have so far been unable to agree on another tranche of federal aid, despite a consensus among policymakers and experts that more stimulus is necessary to prop up the economy during the winter months before a coronavirus vaccine becomes widely available. Another 311,675 people filed claims through the Pandemic Unemployment Assistance program last week, which covers people not eligible for traditional state benefits like freelancers and gig workers.

20.5 million. That’s how many people received some form of government unemployment benefit last week. A recent report from the Century Foundation showed that when the Pandemic Unemployment Assistance Program and another emergency unemployment aid program expire at the end of December, 12 million people will lose benefits. Coronavirus cases continue to surge in the United States ahead of the holiday season. Two million cases were reported in a span of just two weeks, the New York Times reported, and more states and cities are imposing new restrictions to curb the spread of the virus. Nick Note: As the virus spreads the economy will suck shut again. After the No Thanks giving major super spreader event the shutdowns will only get worse. Then you got Christmases and many people will not me able to say NO.  And that means the worst will hit in January and February, And lockdowns will be enforced from one end of the country to the other. And vaccinations just STARTING by then will do nothing. Sooner or later the enormity of the double dip recession will be apparent to all. kicking and screaming along the way the stock market will empty the pockets of another group of suckers as it crashes!

Airlines stir doubts among health experts with claims of safe flying

Airlines have loudly insisted that it’s safe to fly during the coronavirus pandemic, and U.S. travel is surging before the Thanksgiving holiday despite a nationwide spike in virus cases.

Yet top U.S. infectious-disease experts say the findings underpinning the carriers’ safety claims aren’t that conclusive.

Concerned about the “misinterpretation” of their findings, researchers on a Defense Department study that has been widely cited by the industry added a cautionary revision.

A senior expert in travel-health issues declined to participate in an airline trade group’s news conference, citing what he called their “bad math.”

“The airline industry got a little ahead of itself trying to say the risk is zero,” said David Freedman, a University of Alabama at Birmingham professor emeritus who balked at appearing with an International Air Transport Association event that cited his work. U.S. airlines, hit with an unprecedented drop in demand since the virus began spreading widely in March, are enjoying their strongest week since then. Even as health officials warn against travel during the Thanksgiving holiday because of a surge in covid-19 cases, more than 4 million people traversed airports between Friday and Monday. The risk of being infected with the novel coronavirus on planes, which have highly effective filters that remove virus from the air and where mask usage is required, is probably fairly low, scientists say.

But the research is far from clear and some recent cases have documented transmission on flights even when passengers wore masks and sat far apart, according to a review of recent cases and interviews with academics and disease specialists.

“I definitely can say it’s premature to say that air travel is very safe,” said Qingyan Chen, an engineering professor at Purdue University in Indiana who’s written extensively on disease transmission on planes. Airline officials, responding to the historic drop in passengers, repeatedly have defended the protections against infection on flights. “Flying is safe,” Nicholas Calio, president of Airlines for America, a trade group for large carriers, said at a Nov. 12 briefing. “I will state that categorically.” A4A declined to add additional comments. It has highlighted the efforts to force passengers to wear masks and to remain apart during boarding and exiting, and to disinfect aircraft. Montreal-based IATA defended its use of Freedman’s data on confirmed in-flight transmissions, saying it never characterized the results as definitive. A4A frequently has cited a study by the Harvard T.H. Chan School of Public Health, which was funded by the trade group and other aviation industry sources, that concluded the risk of transmission on an airliner was “very low.” But authors cautioned that their projections depended on adherence to mask usage and they also urged airlines to improve ventilation while planes are parked at the gate. Another study airlines point to was conducted by the Defense Department with the assistance of United Airlines Holdings Inc. and Boeing Co. It attempted to measure how aerosol virus particles were exhaled by a simulated masked passenger. United said in promotional materials released Oct. 15 the study “determined the risk is almost nonexistent.”

However, after news coverage of the study, the authors added a revision, saying they were “concerned about the potential misinterpretation of the findings.” They also acknowledged they based their results on a person exhaling relatively few virus particles, an amount well below levels documented in some cases.

The airplane filters and mask usage “significantly reduces” exposure to infectious aerosols, they wrote. “However, the current established scientific understanding of SARS-CoV-2 transmission dynamics is not sufficient to calculate definitive SARS-CoV-2 transmission risk from these measurements of aerosol transport The U.S. Centers for Disease Control summarizes the risks from air travel this way on its website: “Most viruses and other germs do not spread easily on flights because of how air circulates and is filtered on airplanes. However, keeping your distance is difficult on crowded flights, and sitting within six feet of others, sometimes for hours, may increase your risk of getting covid-19.” Purdue’s Chen said he’s been following news reports in China of possible infection between passengers on a Nov. 9 Air China flight from Los Angeles to Tianjin. Ten people who weren’t connected to one another and resided in different parts of the U.S. tested positive for the coronavirus after arrival. All the passengers had tested negative for the disease before the flight, suggesting at least some of the transmission occurred on the plane, he said.

Such incidents are confounding because they seem to contradict Chen’s own earlier research showing mask usage can dramatically lower risks of infection, he said.

“That’s why I’m having doubts about what’s going on in airplanes,” he said. Government researchers in Ireland documented as many as 13 cases linked to a single flight last summer, according to a paper published in October. The infections in five of the cases were genetically linked, “strongly suggesting a single point source of infection,” the authors said. The widebody jet was largely empty, people were spaced out on the plane and almost everyone whose activity could be documented said they wore masks. Nevertheless, the authors estimated that 10-18% of passengers became infected. “It is interesting that four of the flight cases were not seated next to any other positive case, had no contact in the transit lounge, wore face masks in-flight and would not be deemed close contacts under current guidance from the European Centre for Disease Prevention and Control,” the authors said. Nick Note: Proof your  stupid is you get on a airplane with your N95 joke toilet paper mask in hand. You fly you die or you give the gift that keeps on giving. The deadest plague in 100 years. People is it worth the risk?